NS 2710

Drug Profile

NS 2710

Alternative Names: LS-193,970; ME 3127

Latest Information Update: 28 Mar 2002

Price : $50

At a glance

  • Originator NeuroSearch
  • Class Antiepileptic drugs; Anxiolytics; Benzimidazoles; Hypnosedatives; Neuroprotectants; Oximes
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 28 Mar 2002 Discontinued - Phase-I for Anxiety disorders in United Kingdom (unspecified route)
  • 28 Mar 2002 Discontinued - Phase-I for Anxiety disorders in Japan (unspecified route)
  • 28 Mar 2002 Discontinued - Phase-II for Anxiety disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top